Stock Valuation Guides: DCF, P/E, and Multiples Explained

No single method works for every company. Experienced analysts triangulate across three approaches:

• Discounted cash flow (DCF). The theoretically correct method — price equals the present value of future free cash flows. Best for mature, FCF-positive businesses where you can reasonably model the next 5–10 years. Useless for pre-revenue companies or those with highly cyclical or lumpy FCF.
• Relative multiples. Compare the stock to peers on P/E, EV/EBITDA, EV/Revenue, or P/FCF. Fast and practical, but dangerous in isolation — it tells you whether the stock is cheap or expensive relative to peers, not whether the whole sector is mispriced. Use multiples to calibrate DCF outputs, not replace them.
• Asset-based / sum-of-the-parts (SOTP). Value each business segment or asset separately, then sum and subtract net debt. Best for conglomerates, holding companies, or asset-heavy businesses (real estate, mining) where the operating model is secondary to balance sheet composition.

The most robust valuation uses all three. If DCF says $80, EV/EBITDA says $95, and SOTP says $72, you have a range with $75–85 as the credible zone — not a single price target that implies false precision. Try the Intrinsic Value Calculator to get a quick per-share estimate with margin of safety built in.

A DCF has many inputs but three dominate the output:

• Free cash flow growth rate (years 1–5). The near-term forecast. Anchor this to actual business mechanics: revenue growth, margin trajectory, capex intensity. Do not extrapolate recent growth linearly — check for mean reversion signals in margins and competition.
• Terminal growth rate. The perpetuity growth rate applied after your forecast period — typically 2–4% for a stable US business (roughly in line with nominal GDP). Every basis point matters here because it applies to a perpetuity. A 3% vs. 4% terminal rate can swing intrinsic value by 15–25% on a high-multiple stock.
• Discount rate (WACC). The weighted average cost of capital — blends cost of equity and after-tax cost of debt. For large-cap US equities, 8–10% is typical. For high-growth or unprofitable companies, 12–15% is more defensible. A lower discount rate inflates every future cash flow — analysts gaming DCFs tend to shave discount rates, not change growth assumptions.

Run sensitivity tables on these three inputs before trusting any DCF output. If your investment thesis only works at a 7% discount rate and 5% terminal growth, you should know that before buying.

Multiples are context-dependent. Using the wrong one for the wrong business type is a common and costly error:

• P/E. Simplest and most widely cited — but distorted by leverage, non-cash charges, and tax timing differences. Useful for comparing similar businesses with similar balance sheets. A P/E of 25x is cheap for a company growing EPS at 30%; it's expensive for a company growing at 5%. Never look at P/E without looking at the earnings growth rate alongside it.
• EV/EBITDA. The standard for M&A and LBO analysis because it's capital-structure neutral (enterprise value captures both equity and debt). Better than P/E when comparing companies with different leverage ratios or depreciation policies. Sector medians: software 20–30x, industrials 8–12x, banks N/A (use P/B or P/TBV instead).
• EV/FCF (or P/FCF). The most honest multiple for FCF-heavy businesses because it doesn't rely on EBITDA adjustments or accounting choices. If a company trades at 40x EBITDA but 20x FCF, it's a lower-capex, lower-maintenance business than the EBITDA multiple suggests — and may be cheaper than it appears.
• P/S (price-to-sales). Used for unprofitable growth companies as a proxy for future earnings potential. Low P/S only matters if the business can reach meaningful margins at scale — a P/S of 3x on a 5% gross margin business is not cheap. Compare P/S to gross margin percentages, not standalone.

When you buy a share of Microsoft, you are not buying a ticker symbol. You are buying a fractional ownership stake in a business that collects cash from customers every month — Azure contracts, Office 365 subscriptions, Xbox Game Pass renewals. In fiscal 2024, that business generated roughly $74 billion in free cash flow. Your share of that cash flow, and every dollar of cash flow the business produces in every future year, is what you actually own. Intrinsic value is simply the present value of all those future cash flows, discounted back to today. Nothing more complicated than that.

The market price is something different. It is what another investor will pay you right now to take that stream of future cash flows off your hands. On any given day, Microsoft's market cap sits around $3 trillion — roughly 35 times its trailing earnings. That price is set by supply and demand, sentiment, momentum, and the marginal buyer's willingness to pay. It has nothing inherently to do with what the business is actually worth.

The gap between those two numbers is where investing happens. If intrinsic value is $400 per share and the market is offering the stock at $320, you have a margin of safety. If the market is pricing it at $500 and intrinsic value is $380, you are paying for growth that may never materialize. The market is not always wrong — but it is frequently emotional, short-sighted, and crowded. Your edge is patience and a better estimate of the long-run number.

Here is why a stock at all-time highs can still be cheap. Microsoft traded at $25 in 2010. It looked expensive to many investors then — the stock had gone nowhere for a decade. But the business was quietly building what would become a $100 billion cloud division. An investor who estimated future cash flows correctly, rather than anchoring to the recent price history, saw the gap clearly. The stock has returned over 2,000% since.

The job is not to find cheap-looking stocks. It is to find businesses whose future cash flows the market is underestimating. Price is what you pay. Intrinsic value is what you get. When those two numbers diverge enough, that is the opportunity.

Every valuation multiple is a question. The multiple you choose determines what you're actually asking about a business — and each one has a blind spot.

P/E is the most widely quoted multiple, but it's built on GAAP earnings — the most manipulable number a company reports. Depreciation schedules, stock-based compensation treatment, one-time charges: accountants have enormous latitude here. When you pay 25x earnings, you're paying 25x a number that finance teams spend considerable effort shaping. P/E is useful for mature, asset-light businesses with predictable, clean earnings. It breaks down for capital-intensive companies, high-growth names reinvesting aggressively, or any company carrying a messy balance sheet.

EV/EBITDA solves the capital structure problem. Enterprise value (market cap plus net debt) replaces market cap, so you're valuing the whole business — not just the equity slice. EBITDA strips out interest expense, which means a company levered to the hilt looks comparable to one with no debt. That's useful for cross-company comparisons and LBO analysis. The catch: EBITDA ignores capital expenditures. A railroad and a software company can report identical EBITDA margins, but the railroad needs to spend billions maintaining track. EV/EBITDA treats them the same. It's a starting point, not a final answer.

P/FCF gets closest to the question that actually matters: how much cash does this business generate for its owners? Free cash flow — operating cash flow minus capex — is harder to manipulate than earnings and more complete than EBITDA. Netflix in 2023 is the clearest recent example. The company reported roughly $5.1B in GAAP net income. But it generated approximately $6.9B in free cash flow, because stock-based compensation and other non-cash charges depressed reported earnings without touching actual cash. A P/E buyer saw one price. A P/FCF buyer saw a business roughly 35% cheaper on cash generation. That gap matters enormously when you're sizing a position.

No single multiple works across all businesses. Use P/FCF for mature compounders where cash conversion is the story. Use EV/EBITDA when comparing across capital structures or evaluating a potential acquisition. Use P/E only when earnings are clean and capex is minimal. For early-stage or unprofitable companies, shift to EV/Revenue or EV/Gross Profit — you're buying a future earnings stream, not a current one. The worst mistake isn't picking the wrong multiple. It's applying one mechanically without asking what it's actually measuring.

Getting the business right is the easy part. Valuation is where most money is lost — not because investors picked the wrong company, but because they used the wrong framework to determine what to pay. Three mistakes cause most of the damage.

1. Anchoring to a historical multiple that no longer applies. Netflix traded at 60x earnings during its peak-growth years; that multiple reflected subscriber expectations that no longer held by 2022. When growth stalled, the stock fell 75%. Investors who called it "cheap relative to history" were anchoring to a multiple built on a thesis that had expired. Intel tells the same story in reverse: 16x earnings made sense when it owned CPU manufacturing; losing fabrication ground to TSMC and data center share to AMD means that multiple no longer applies.
2. Ignoring the denominator. A 20x P/E on declining earnings is more expensive than a 25x on growing ones — and investors forget this constantly. Walgreens looked cheap at 10x earnings in 2022; earnings have since fallen more than 50%, meaning buyers were really paying 20x+ on what the business actually delivered. The same trap springs every commodity cycle: a steel company at 8x P/E at peak earnings isn't cheap. Those earnings won't hold, and the multiple expands painfully when the cycle turns.
3. Confusing a great business with a great investment. Visa is one of the finest businesses in the world — 65%+ operating margins, no credit risk, a near-duopoly with Mastercard on global card payments. The market knows this, which is why the stock trades around 31x earnings. At that multiple, even 12% annual earnings growth gives you a starting earnings yield of roughly 3.2% — not a disaster, but not the bargain the business quality implies. The mistake is letting admiration for the company substitute for analysis of the price.

Every valuation is a bet on the future. The problem is that analysts build models around their best guess, then treat that guess as fact. Stress-testing forces the opposite discipline: build the base case, then systematically destroy it. A valuation that only works under optimistic assumptions isn't a valuation — it's a wish. The goal is to find where the thesis breaks, because that's where the real risk lives.

1. Write down every assumption explicitly. Before you touch a scenario, list the inputs driving your model: revenue growth rate, operating margin, terminal growth rate, discount rate. For a mid-cap SaaS stock trading at 35x forward earnings, your base case might be 12% annual revenue growth, 20% operating margins at maturity, 3% terminal growth, 10% discount rate. These are the levers. Now you can pull them.
2. Run three scenarios — and make the bear case honest. Bull case: 20% growth, margins expand to 25%. Base case: 12% growth, margins hold at 20%. Bear case: 5% growth — roughly what happens if one major contract churns or a competitor undercuts pricing. Don't soften the bear case to make yourself feel better. The bear case should reflect something that could plausibly happen within 18 months.
3. Calculate intrinsic value for each scenario. Run a simple DCF or reverse-engineer the implied multiple. In this example: bull case yields $95 intrinsic value, base case $62, bear case $31. The stock trades at $58. The base case barely supports the current price. The bear case implies 46% downside. That asymmetry is the finding — not the price target.
4. Ask what has to be true for the stock to work. If intrinsic value only exceeds the current price under the bull scenario, you're not buying a stock — you're buying a forecast. Identify the single assumption that matters most. For growth stocks, it's almost always the revenue growth rate in years three through five. A drop from 15% to 8% often cuts intrinsic value by 30–40%. That's not a catastrophic outcome. That's a normal business quarter.